8/12/2009

Sun Pharmaceutical Industries obtained FDA clearance for its generic copies of GlaxoSmithKline's migraine drug Imitrex and Sanofi-Aventis' cancer drug Eloxatin. The Indian company said it will share a 180-day market protection for generic Eloxatin with three other drug firms.

Full Story:
Reuters

Related Summaries